SK Chemicals to establish production of vaccines in Russia

Russian drugmaker Nanolek has reached an agreement with SK Chemicals on the establishment of production of vaccines at the facilities of the company’s Russian plant, which is located in Kirov region, reports The Pharma Letter's local correspondent.

Under the terms of the agreement, SK Chemicals will transfer its technology for the production of vaccines against rotavirus infection and infection caused by the human papillomavirus to Nanolek, a joint venture between RusNano with Russian biotechnology company Epidbiomed and one of Russia’s largest drugmakers.

Both vaccines are not currently included in the Russian National Vaccine Prevention Calendar for general immunization, but are recommended by doctors.